Related references
Note: Only part of the references are listed.Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors
Y. Amemiya et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis
Nigel B. Jamieson et al.
CLINICAL CANCER RESEARCH (2011)
Positive Expression of L1-CAM is Associated with Perineural Invasion and Poor Outcome in Pancreatic Ductal Adenocarcinoma
Qi-Wen Ben et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype
Hiromu Suzuki et al.
CARCINOGENESIS (2010)
IGFBP7: an oncosuppressor gene in thyroid carcinogenesis
M. G. Vizioli et al.
ONCOGENE (2010)
The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer
Hartwig Riediger et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines
Narendra Wajapeyee et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Tumor-node-metastasis staging of pancreatic adenocarcinoma
Matthew H. G. Katz et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25
Yuichiro Sato et al.
CANCER SCIENCE (2007)
IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis
Wenjing Ruan et al.
CANCER BIOLOGY & THERAPY (2007)
Insulin-like growth factor binding protein-related protein I (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer
Y. Chen et al.
JOURNAL OF PATHOLOGY (2007)
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
Jordan M. Winter et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1
GE Walker et al.
ONCOGENE (2006)
Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach
M Gronborg et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer
AM Burger et al.
EUROPEAN JOURNAL OF CANCER (2005)
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma
S Yamamoto et al.
CLINICAL CANCER RESEARCH (2004)
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi et al.
CANCER (2003)
Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas
KJ Stanton et al.
AMERICAN JOURNAL OF SURGERY (2003)
Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma
AI Sarela et al.
BRITISH JOURNAL OF CANCER (2002)
Over-expression of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis
CC Sprenger et al.
ONCOGENE (2002)
Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors
G Landberg et al.
ONCOGENE (2001)
Resected adenocarcinoma of the pancreas - 616 patients: Results, outcomes, and prognostic indicators
TA Sohn et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2000)
Share Paper
